Newton Charles W. bought CHRS
June 5, 2026 · Form 4 insider transaction
Newton Charles W. bought 60,000 shares of Coherus Oncology, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
60,000
Price
$0.00
Total value
N/A
InsiderNewton Charles W.
RoleOfficer, Director
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJune 5, 2026
Filing dateJune 9, 2026
Shares owned after60,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The underlying shares vest and become exercisable as to 100% of the total number of the shares subject to the option on June 3, 2027, subject to the Reporting Person's continued service relationship with the Issuer on such vesting date.